NVNovoCure NVCR · NASDAQ
$14.68 -2.78% (-$0.42)
- Market cap
- $1.73B
- Enterprise value
- $1.87B
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 2.5x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -26.2%
- Bruto marža
- 76.1%
- Neto marža
- -21.2%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 0.99
- Free float
- 82.8%
O podjetju
NovoCure Limited is an international biotechnology company specializing in the development of innovative therapies for cancer treatment. The company is known for its unique Tumor Treating Fields (TTFields) technology, which uses electric fields to target and treat tumors, inhibiting their growth. TTFields is a non-invasive treatment that is used for various types of cancer, including brain cancer, lung cancer, and more. NovoCure focuses on providing new therapeutic approaches that can improve treatment outcomes and the quality of life for patients suffering from cancer.
Sector
Healthcare
Industry
Medical - Devices
CEO
Frank Leonard
Employees
1,605
Headquarters
Baar
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke